Clal Biotechnology reported ILS-5155000 in Interest Income for its fiscal quarter ending in December of 2022.


Interest Income Change Date
Compugen USD 1.07M 1.39M Jun/2025
Life Technologies USD 10.93K 10.93K Jun/2025
RedHill Biopharma USD 7.1M 14.49M Jun/2023